IXP Launches Lifesciences Catalyst Fund for Early-Stage Investments

IXP marks its entry into the investing landscape with the announcement of its Lifesciences Catalyst Fund, focusing on early-stage ventures. This fund is specifically designed to develop a portfolio of B2B companies at various stages, including pre-seed and Series A rounds.

Fund Details and Investment Focus

The IXP Lifesciences Catalyst Fund has set a goal to raise a corpus of Rs 200 crore, along with a greenshoe option amounting to Rs 100 crore. The fund intends to build a diversified portfolio consisting of 20-25 companies that aim to fill existing gaps in the market for both products and services. Within the expansive realm of Life Sciences, the fund is set to support innovations across numerous areas, including pharmaceuticals, biotechnology, medical technology, specialty chemicals, agrotechnology, and nutraceuticals.

Co-Creation and Support via IXP Venture Studio

Through the IXP Venture Studio, this initiative plans to collaborate with scientists to co-create companies that address unmet market needs. Unlike conventional venture capital firms, IXP adopts a proactive engagement strategy, being involved in the journey from conceptualization to scaling operations. The Venturepreneur Program is specifically crafted to empower scientists, transforming them into successful founders.

Providing Essential Ecosystem Access

IXP recognizes that emerging companies typically need access to broader ecosystems, which include laboratories, networks, and R&D services. These resources are available through PoweRx, the Life Sciences division of JV Ventures. By harnessing the synergies within its group, IXP creates a compelling value proposition for the companies in its portfolio.

Supporting Innovation in Life Sciences

IXP, short for Innovation Acceleration Platform, is committed to aiding scientists and innovators in their entrepreneurial ventures, seamlessly integrating them into a robust life sciences ecosystem. The venture capital firm is built upon a solid foundation of expertise, fully aware of the capital demands and lengthy timelines often associated with R&D, thus helping to propel innovative concepts into the marketplace.